Stay updated on Nivolumab Combo in Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Smoldering Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRemoved the old government funding operating-status notice and the prior Revision: v3.4.1; added Revision: v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, informing users that information may not be up to date and the NIH Clinical Center is open with status updates at opm.gov. The page version indicator was updated to Revision: v3.4.1 and the previous Revision: v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle is now visible on the page. The page now displays a 'Last Update Submitted that Met QC Criteria' label, includes a 'No FEAR Act Data' notice, and shows 'Revision: v3.4.0' in the footer.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor site update with no changes to trial details.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Massachusetts and updated page revision to v3.3.3. The old Massachusetts Locations label and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page now displays revision v3.3.2, replacing the previous v3.3.1 revision.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Smoldering Myeloma Clinical Trial page.